Book
After 13 years there are new areas to discuss and more recent trials to beincluded. Good clinical practice evaluation of quality of life measurement ofthe benefitrisk comparison determination of cost effectiveness and costutility stopping rules for trials metaanalysis and subgroup analysis are allnew sections. The references are expanded from 305 to 512 and include therecent advances in trial design such as the emnemof1 trials and megatrialsand uptodate examples to illustrate the points made in the 20 chapters. «
Boeklezers.nl is a network for social reading. We help readers discover new books and authors, and bring readers in contact with each other and with writers. Read more ».
There are no reviews for this book yet.